Attorney Jessica Paluch-Hoerman, founder of TruLaw, has over 28 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Question: Am I eligible for a Depo Provera lawsuit?
Answer: You may be eligible to file a Depo Provera lawsuit if you received Depo-Provera injections for birth control and subsequently developed serious health complications.
Individuals who used brand-name Depo Provera, Depo-SubQ Provera, or an authorized generic version at least twice and were later diagnosed with a meningioma or brain tumor may qualify for Depo Provera claims.
Depo Provera birth control is a widely used contraceptive injection that has been prescribed to millions of women since FDA approval in 1992.
This injectable contraceptive has been marketed as a convenient birth control injection option for decades.
Recent scientific studies have revealed a potential link between long-term Depo Provera use and the development of meningiomas, a type of brain tumor demonstrating concerning tumor growth patterns.
These findings have prompted new Depo Provera lawsuits from women who developed brain tumors after using this birth control method.
On this page, we’ll discuss this question in further depth, the link between Depo Provera and meningioma brain tumors, recognizing symptoms and warning signs of meningiomas, and much more.
Depo Provera was first introduced in the United States in 1959 for management of menstruation and was approved for contraceptive use by the U.S. Food and Drug Administration (FDA) in 1992.
The medication contains the hormone medroxyprogesterone acetate (MPA), a synthetic form of the hormone progestin that works by suppressing ovulation and thickening cervical mucus to prevent pregnancy.
The Depo Provera shot has gained widespread popularity due to its convenience, requiring only one shot every three months.
Both forms are FDA-approved and must be administered every 12 weeks to be effective.
There are two primary formulations available:
According to the Centers for Disease Control and Prevention, about 25% of all sexually experienced women have used the injectable contraceptive Depo Provera at some point.
This widespread usage creates a major safety concern for the millions of women who have relied on this birth control injection over the past several decades.
If you or a loved one developed a brain tumor after using Depo Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo Provera lawsuit today.
In March 2024, a major new scientific study was released, which found a clear link between the use of Depo-Provera and the development of a specific type of brain tumor called a meningioma.
The new study was published in the renowned British Medical Journal.
This groundbreaking research examined data from over 100,000 women in France, making it one of the largest studies demonstrating how Depo Provera caused serious health issues.
The findings were striking: According to a March 2024 study in the BMJ, women who use Depo shots for at least a year are 5 times more likely to develop meningioma brain tumors.
This represents a 5.6-fold increased risk compared to women who did not use the contraceptive, highlighting serious health risks associated with this medication.
What makes these findings particularly concerning is that evidence of this risk has existed for decades.
Indeed, it’s been alleged that an association between progesterone and meningiomas has been known since at least 1983, nearly a decade before healthcare providers began prescribing Depo Provera for contraception.
Despite this knowledge, manufacturers failed to adequately warn patients about these potential risks in the United States.
The revelation of these risks has sparked a wave of legal action against Pfizer and other manufacturers.
The first Depo Provera lawsuits filed occurred in October 2024 by a California woman who was diagnosed with a meningioma when she was 37 years old.
Since then, the litigation has grown rapidly.
The Judicial Panel on Multidistrict Litigation (JPML) consolidated more than 290 cases into Depo Provera multidistrict litigation in the Northern District of Florida under Judge Casey Rodgers as of May 2025.
This consolidation, known as MDL No. 3140, streamlines the pretrial process, enabling more efficient handling of these cases.
Key developments in the litigation include:
Since its formation, the Depo-Provera MDL has continued to grow.
As of April 2025, over 130 cases have been filed in the MDL, and legal experts anticipate that number will increase as more women become aware of Depo Provera side effects.
With millions of women having used this contraceptive over the past three decades, the potential scope of this litigation could be substantial.
Medical research has established a concerning connection between prolonged Depo Provera use and increased risk of developing meningiomas.
These brain tumors, while typically non-cancerous, can cause severe health issues and may require surgical intervention.
The risk appears to increase with both duration of use and cumulative dose exposure.
A meningioma is a primary tumor of the central nervous system (CNS).
This means it begins in the brain or spinal cord.
Overall, meningiomas are the most common type of primary brain tumor.
These tumors develop in the meninges—the protective layers of tissue that surround the brain and spinal cord.
Meningioma grading (I to III) is based on the microscopic appearance of the tumor cells.
The World Health Organization classifies meningiomas into three grades:
Even benign meningiomas can grow large enough to be life-threatening if they compress and affect nearby areas of your brain.
While most meningiomas are not cancerous, their location and size can still lead to major health problems requiring medical intervention.
The groundbreaking 2024 BMJ study provided compelling evidence of the link between Depo Provera and meningiomas.
Researchers analyzed French health system data for more than 18,000 women who underwent surgery for intracranial meningioma between 2009 and 2018.
The study included 108,366 women, with 18,061 women who had undergone surgery for meningioma.
The key findings were alarming:
Importantly, this was not the first evidence of risk.
Studies linking Depo-Provera to meningioma go back to 1983, when researchers discovered that synthetic hormones could stimulate progesterone receptors in these tumors.
Despite decades of warning signs, manufacturers in the United States failed to adequately inform patients about how Depo Provera works and its effects on brain tissue.
The biological mechanism underlying this increased risk is related to hormone receptors found in meningiomas.
Researchers noted that progesterone receptors are present in more than 60% of meningiomas, which may help explain the observed risk.
Depo Provera contains medroxyprogesterone acetate (MPA), a synthetic form of progesterone.
When this synthetic hormone binds to progesterone receptors in meningeal tissue, it may stimulate abnormal cell growth and tumor development.
NF2 is the gene that gives rise to a condition called Neurofibromatosis 2, an inherited genetic disorder characterized by the development of schwannoma, ependymoma, and meningioma tumours in the brain and spinal cord.
Approximately 40% to 60% of meningiomas are associated with a mutation of the NF2 gene.
The prolonged exposure from regular Depo Provera injections appears to be a key factor in this development.
Since each injection provides contraceptive protection for three months, women using this method accumulate major hormone exposure over time.
Given that medroxyprogesterone acetate is used by approximately 74 million women globally, the researchers called for further investigation into the safety of specific hormones and their role in causing tumor growth and other serious health complications.
Women who have used Depo Provera should be aware of potential symptoms that may indicate the presence of a meningioma.
Early detection can impact treatment outcomes and overall quality of life.
If you experience any of these symptoms and have a history of Depo Provera use, medical evaluation is recommended.
More common symptoms of brain meningiomas include, but are not limited to:
These symptoms develop as the tumor grows and puts pressure on surrounding brain tissue.
The most frequently reported symptom is headaches, which often have specific characteristics.
These headaches are worse in the morning, as the patient wakes up, and improve gradually throughout the day.
Unlike typical headaches, these tend to be persistent and worsen over time rather than responding to over-the-counter pain medications.
You may also notice your vision is becoming blurry, or you start seeing double.
These visual disturbances may start subtly but progressively worsen as the tumor grows.
About 20% to 50% of people who have a meningioma will experience a seizure.
These can range from brief episodes affecting only vision or speech to more severe seizures involving loss of consciousness and muscle control.
Beyond the more typical symptoms, meningiomas can cause various neurological issues depending on their location.
Muscle weakness in certain areas of your body.
Paralysis in certain areas of your body.
These symptoms often develop gradually and may initially be mistaken for other conditions.
Anterior skull base meningiomas are frequently associated with changes in personality and behavior.
Location – Olfactory Groove and sella (bony space where the pituitary gland is situated) Common Symptoms – Loss of smell (anosmia), subtle personality changes, mild difficulty with memory, euphoria, diminished concentration, urinary incontinence, visual impairment.
Speech difficulties can also indicate the presence of a meningioma.
Some people with brain tumours can have difficulty finding words when speaking, difficulty physically speaking, or struggle using specific language.
These communication problems may start as occasional word-finding difficulties and progress to more major speech impairments.
Meningiomas might present with mood symptoms, psychosis, memory disturbances, personality changes, anxiety, or anorexia nervosa.
These psychiatric symptoms can sometimes be the only manifestation of a brain tumor, leading to delayed diagnosis when patients are initially treated for mental health conditions.
A meningioma is usually benign, although a small percentage are malignant (cancerous).
The tumour typically grows slowly and doesn’t spread to any other part of the body.
However, even benign meningiomas require medical attention when symptoms appear.
You should seek immediate medical evaluation if you experience:
A meningioma diagnosis is made after an imaging exam.
If you have used Depo Provera for an extended period and are experiencing any concerning symptoms, it’s vital to inform your healthcare provider about your contraceptive history.
This information can help guide appropriate diagnostic testing.
When discussing your symptoms with a healthcare provider, be sure to mention:
Early detection through proper medical evaluation can lead to better treatment outcomes and may strengthen any potential legal claim if you’ve been harmed by Depo Provera use.
Not everyone who used Depo Provera will qualify for legal action.
Specific criteria must be met to establish a viable claim against the manufacturers.
An experienced attorney can evaluate your individual circumstances to determine if you have grounds for filing lawsuits related to Depo Provera side effects.
To qualify for a Depo Provera lawsuit, several key criteria must be met.
To qualify for a lawsuit, individuals must have used the brand-name (Pfizer) Depo-Provera, depo-SubQ Provera, or an authorized generic version at least twice and must have been diagnosed with a meningioma or brain tumor after usage.
The primary requirements include:
Anyone who intends to take legal action against Pfizer over a brain tumor stemming from Depo-Provera use must have as much official documentation of their condition as possible, including comprehensive records of their initial diagnosis as well as all treatment received and prescription medications taken since that diagnosis.
Important documentation includes:
Providing evidence of Depo Provera use will be central to this litigation.
If you received injections many years ago, pharmacy records, insurance claims, or medical billing statements may help establish your usage history.
Several factors can influence your eligibility and the strength of your claim when filing lawsuits.
Learning these considerations is important before pursuing legal action:
If you believe you meet these criteria, it’s important to act quickly.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo Provera lawsuit today.
Women who develop meningiomas after Depo Provera use may have several legal avenues available.
The type and amount of compensation can vary based on individual circumstances and the severity of injuries.
A qualified attorney can help identify the best legal strategy for your situation involving depo provera claims.
Depo Provera lawsuits typically fall under product liability law, with several legal theories available to pursue compensation.
Product liability actions are often quite challenging.
Establishing legal fault usually requires expert testimony.
This is especially true in cases involving scientific or medical issues, such as those involving defective drugs.
The primary legal theories include:
This structure is particularly suitable for Depo-Provera litigation, where injuries, such as meningiomas associated with high-dose progestin, require personalized evaluations of damages and circumstances.
Unlike class action lawsuits, where all plaintiffs share equally, an MDL allows for individual assessment of each woman’s unique damages.
Victims of Depo Provera-related brain tumors may be entitled to various forms of compensation.
If you have grounds to file a lawsuit, it may be possible to obtain a settlement that covers your past and future damages.
Punitive Damages: Additional sums meant to punish Pfizer for neglect.
These may be awarded in cases where the manufacturer’s conduct was particularly egregious, especially when the discontinuation of Depo Provera warnings was inadequate.
Learning what to expect during litigation can help you make informed decisions about pursuing a claim.
In many mass tort MDLs, settlements are reached before bellwether trials begin.
The typical process includes:
Current settlement projections vary widely based on case specifics.
If the evidence supporting causation holds up in court, our lawyers estimate that Depo-Provera brain tumor cases involving major complications could result in settlement payouts ranging from $275,000 to $500,000.
Payouts may exceed these estimates based on the circumstances of the case, the severity of the injuries, and provable damages.
A 2020 analysis of 47 meningioma lawsuits has caught the attention of legal professionals investigating cases involving women who used Depo-Provera.
The study found that in 68.1% of cases, failure to diagnose was the primary basis for legal action.
Notably, the average verdict in these lawsuits amounted to $3,409,650.22, with settlements averaging $867,555.56.
If you or a loved one developed a brain tumor after using Depo Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo Provera lawsuit today.
If you believe you may qualify for a Depo Provera lawsuit, taking prompt action is important.
The legal process can seem overwhelming, but working with experienced attorneys can help protect your rights.
Here’s what you should do to move forward with a potential claim.
The first priority after a meningioma diagnosis is your health and safety.
If you’re currently using Depo Provera, consult with your healthcare provider about alternative contraceptive options.
Do not stop any medication without medical guidance, as your doctor can help you transition safely to another birth control method when discontinuing Depo Provera.
Begin gathering and organizing your medical documentation immediately.
Before you send your medical record request documents, check each facility’s website for any available instructions.
Important records to collect include:
While physicians’ documentation efforts tend to focus on the content of the clinical encounter, communication with patients at the time of and after discharge is equally important for minimizing liability.
Create a personal timeline documenting:
Keep detailed records of all expenses related to your condition, including medical bills, travel costs for treatment, and any lost wages due to missed work.
Selecting an experienced attorney is vital for the success of your case.
These cases can get large and challenging, thus requiring the assistance of an experienced pharmaceutical lawyer.
Look for firms with a proven track record in mass tort cases against major pharmaceutical companies.
Resources and Infrastructure: From our groundbreaking lawsuit against the tobacco industry to the representation of over 500 women in the Dalkon Shield cases, to the cases we are working on, many of our mass tort lawyers have been listed as Super Lawyers and in Best Lawyers in America.
Ensure the firm has adequate resources to take on large corporations like Pfizer.
Communication and Support: Your attorney should provide clear communication about your case status and be available to answer questions throughout the process.
Questions to ask potential attorneys include:
TruLaw has extensive experience representing women harmed by dangerous pharmaceutical products.
Our team, led by Jessica Paluch-Hoerman, combines legal expertise with a commitment to making justice accessible for all clients.
Learning the legal process can help you prepare for what lies ahead.
During the discovery phase of the lawsuit, both sides investigate the facts.
Plaintiffs and defendants exchange documents such as company emails and other records.
Continue following your doctor’s treatment recommendations and keep detailed records of all medical appointments and expenses.
If you or a loved one developed a brain tumor after using Depo Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo Provera lawsuit today.
Our Depo Provera attorney at TruLaw is dedicated to supporting clients through the process of filing a Depo Provera lawsuit.
With extensive experience in dangerous drugs cases, Jessica Paluch-Hoerman and our partner law firms work with litigation leaders and medical experts to prove how Depo Provera injections caused you harm.
TruLaw focuses on securing compensation for medical expenses, bone density treatment costs, pain and suffering, and other damages resulting from your Depo Provera injuries.
We understand the physical and emotional toll that Depo Provera complications have on your life and provide the personalized guidance you need when seeking justice.
Meet our lead Depo Provera attorney:
At TruLaw, we believe financial concerns should never stand in the way of justice.
That’s why we operate on a contingency fee basis—with this approach, you only pay legal fees after you’ve been awarded compensation for your injuries.
If you or a loved one experienced health complications after receiving Depo Provera injections, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo Provera lawsuit today.
Depo Provera lawsuits are being filed by individuals across the country who suffered serious bone density loss and other health complications after receiving the contraceptive injection.
TruLaw is currently accepting clients for the Depo Provera lawsuit.
A few reasons to choose TruLaw for your Depo Provera lawsuit include:
If you or a loved one suffered bone density loss, fractures, or other health problems after receiving Depo Provera injections, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the Depo Provera lawsuit today.
The time limit for filing a Depo Provera lawsuit depends on your state’s statute of limitations.
The statute of limitations for the Depo Provera lawsuit varies by state, typically ranging from two to three years.
However, this deadline can be challenging in pharmaceutical cases.
The discovery rule may apply in some states.
It could extend your deadline to file a Depo-Provera lawsuit.
The countdown to file a lawsuit usually starts from the date you’re diagnosed with the tumor.
But under the discovery rule, the clock starts ticking at the point where you could reasonably connect the tumor to your Depo-Provera use.
Since the BMJ study linking Depo Provera to brain tumors was only published in March 2024, many women are just now discovering the connection between their meningioma and past contraceptive use.
This means the discovery rule may protect your right to file a claim even if you used Depo Provera many years ago.
It’s vital to act quickly despite these potential extensions.
Contact an attorney as soon as possible to ensure your claim is filed within the appropriate timeframe for your state.
Many women worry that using Depo Provera decades ago might disqualify them from legal action.
However, the timing of your usage is less important than when you discovered the link to your brain tumor.
The discovery rule is a legal principle that delays the start of the statute of limitations until a plaintiff knows, or reasonably should know, about both the injury and its connection to the defendant’s conduct.
In the context of Depo-Provera meningioma lawsuits, women who developed brain tumors could not have reasonably suspected the link between their condition and Depo-Provera until recent scientific studies were published.
Key considerations for historical use include:
Even if you cannot locate all your medical records, other evidence such as insurance claims, payment records, or witness testimony from family members may help establish your usage history.
A Depo-Provera class action lawsuit would combine all plaintiffs into a single, unified case, with one trial or settlement covering everyone.
Any compensation would be divided equally among participants, regardless of individual circumstances.
That does not work because the injuries women have suffered are so different.
Instead, Depo Provera cases are being handled through Depo Provera multidistrict litigation (MDL).
Unlike in a class action lawsuit, each case in an MDL remains separate.
If there’s a Depo-Provera settlement, each individual will receive a payout based on the extent and nature of their injuries.
The MDL process offers several advantages:
To join the MDL, you must file an individual lawsuit with the help of an attorney.
Your case will then be transferred to the MDL court for consolidated proceedings.
One of the biggest concerns for potential plaintiffs is the financial burden of pursuing legal action.
Fortunately, most Depo Provera attorneys work on a contingency fee basis.
This means they will only get paid if they win your suit, in which case they will collect a percentage of your Depo-Provera settlement or jury award as payment.
This fee structure means:
Additional costs such as medical record retrieval, expert witness fees, and court filing fees are typically advanced by your attorney and reimbursed from any settlement or verdict.
This arrangement ensures that financial constraints don’t prevent you from seeking justice.
Before signing any agreement, make sure you know the specific percentage your attorney will receive and any costs that might be deducted from your settlement.
At TruLaw, we believe in transparency and will clearly explain all fee arrangements during your initial consultation.
If you or a loved one developed a brain tumor after using Depo Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo Provera lawsuit today.
Managing Attorney & Owner
With over 25 years of legal experience, Jessica Paluch-Hoerman is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share the most reliable, accurate, and up-to-date legal information with our readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Depo Provera Lawsuit claims are being filed by individuals who allege they developed meningioma (a type of brain tumor) after receiving Depo-Provera birth control injections.
A 2024 study found that women using Depo-Provera for at least 1 year are five times more likely to develop meningioma brain tumors compared to those not using the drug.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?